Anti-Infective Drugs Advisory Committee

Anti-Infective Drugs Advisory Committee Committee Meeting September 5, 2012 8:00 a.m. to 5:00 p.m. Agenda: The committee will discuss new drug application (NDA) 201688, tobramycin inhalation powder, application submitted by Novartis Pharmaceuticals Corporation, and the requested indication of management of cystic fibrosis patients infected with the bacterium Pseudomonas aeruginosa.